Viking Therapeutics (NASDAQ: VKTX) now ranks among the hottest biotech stocks on the market. The company's announcement in February of positive results from its phase 2 study of experimental weight loss drug VK2735 provided a huge catalyst.

The future for Viking appears to be bright. But where will this high-flying stock be in 10 years? Here are three potential scenarios.

Viking Therapeutics could be worth much more than its current market cap in 2034. It's not hard to envision a scenario where the company and its stock are thriving.

Continue reading

Source Fool.com